Cargando…

Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma

Latent membrane protein 1 (LMP1) is an important oncogenic protein encoded by Epstein-Barr virus (EBV) and plays an important role in the development of nasopharyngeal carcinoma (NPC). Our previous study has shown that p53 protein was accumulated and phosphorylated in NPC, implying its transcription...

Descripción completa

Detalles Bibliográficos
Autores principales:	GUO, LILI, TANG, MIN, YANG, LIFANG, XIAO, LANBO, BODE, ANN M., LI, LILI, DONG, ZIGANG, CAO, YA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573768/ https://www.ncbi.nlm.nih.gov/pubmed/22266808 http://dx.doi.org/10.3892/ijmm.2012.889

Ejemplares similares

Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy
por: Xiao, L, et al.
Publicado: (2014)

Tyrosylprotein Sulfotransferase-1 and Tyrosine Sulfation of Chemokine Receptor 4 Are Induced by Epstein-Barr Virus Encoded Latent Membrane Protein 1 and Associated with the Metastatic Potential of Human Nasopharyngeal Carcinoma
por: Xu, Juan, et al.
Publicado: (2013)

The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease
por: Selby, Thomas L., et al.
Publicado: (2019)

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
por: Kase, Kina, et al.
Publicado: (2021)

Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy
por: Hu, Jianmin, et al.
Publicado: (2020)

EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma
por: Yang, Lifang, et al.
Publicado: (2015)

C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes
por: Kobayashi, E., et al.
Publicado: (2018)

Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: Erratum
por: Hu, Jianmin, et al.
Publicado: (2022)

Epstein-Barr Virus LMP1 Modulates the CD63 Interactome
por: Cheerathodi, Mujeeb, et al.
Publicado: (2021)

Id1 Interacts and Stabilizes the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) in Nasopharyngeal Epithelial Cells
por: Hau, Pok Man, et al.
Publicado: (2011)

Detection of Epstein-Barr Virus by PCR and Expression of LMP1, p53, CD44 in Gastric Cancer
por: Lee, Myung Ah, et al.
Publicado: (2004)

Transcriptome Changes Induced by Epstein-Barr Virus LMP1 and LMP2A in Transgenic Lymphocytes and Lymphoma
por: Shair, Kathy H. Y., et al.
Publicado: (2012)

Epstein-Barr virus-encoded LMP1 regulated Pim1 kinase expression promotes nasopharyngeal carcinoma cells proliferation
por: Ding, Ran-ran, et al.
Publicado: (2019)

A Systematic Review of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
por: Banko, Ana, et al.
Publicado: (2021)

Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein–Barr Virus LMP1 Protein
por: Khenchouche, Abdelhalim, et al.
Publicado: (2023)

The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A/TGFβ and β1 integrin signalling
por: Morris, Mhairi A., et al.
Publicado: (2016)

Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2 Among Vietnamese Patients with Nasopharyngeal Brush Samples
por: Lao, Thuan Duc, et al.
Publicado: (2017)

Epstein - Barr Virus Transforming Protein LMP-1 Alters B Cells Gene Expression by Promoting Accumulation of the Oncoprotein ΔNp73α
por: Accardi, Rosita, et al.
Publicado: (2013)

The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration
por: Mohr, Caroline F, et al.
Publicado: (2014)

Upregulation of Id1 by Epstein-Barr Virus-encoded LMP1 confers resistance to TGFβ-mediated growth inhibition
por: Lo, Angela KF, et al.
Publicado: (2010)

Interleukins, laminin and epstein - barr virus latent membrane protein 1 (EBV LMP1) Promote metastatic phenotype in nasopharyngeal carcinoma
por: Chew, Michelle MS, et al.
Publicado: (2010)

CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth
por: Huo, Haifeng, et al.
Publicado: (2019)

Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition
por: Hannigan, Adele, et al.
Publicado: (2010)

The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma
por: Tanyildiz, Hikmet Gulsah, et al.
Publicado: (2015)

Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo
por: Lin, Mei-Chun, et al.
Publicado: (2017)

EBV-Encoded LMP1 Upregulates Igκ 3′Enhancer Activity and Igκ Expression in Nasopharyngeal Cancer Cells by Activating the Ets-1 through ERKs Signaling
por: Liu, Haidan, et al.
Publicado: (2012)

Epstein–Barr virus LMP2A imposes sensitivity to apoptosis
por: Swanson-Mungerson, Michelle, et al.
Publicado: (2010)

Cancer-Associated Fibroblasts in Undifferentiated Nasopharyngeal Carcinoma: A Putative Role for the EBV-Encoded Oncoprotein, LMP1
por: Morris, Mhairi A.
Publicado: (2019)

Differential Signaling and Tumor Necrosis Factor Receptor–Associated Factor (Traf) Degradation Mediated by Cd40 and the Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (Lmp1)
por: Brown, Kevin D., et al.
Publicado: (2001)

Epstein-Barr Virus_Encoded LMP1 Upregulates MicroRNA-21 to Promote the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin-Induced Apoptosis by Suppressing PDCD4 and Fas-L
por: Yang, Guang-Da, et al.
Publicado: (2013)

Epstein-Barr Virus-Encoded LMP1 Interacts with FGD4 to Activate Cdc42 and Thereby Promote Migration of Nasopharyngeal Carcinoma Cells
por: Liu, Hao-Ping, et al.
Publicado: (2012)

Characterization of a Suppressive Cis-acting Element in the Epstein–Barr Virus LMP1 Promoter
por: Yoshida, Masahiro, et al.
Publicado: (2017)

Epstein-Barr Virus LMP2A Reduces Hyperactivation Induced by LMP1 to Restore Normal B Cell Phenotype in Transgenic Mice
por: Vrazo, Alexandra C., et al.
Publicado: (2012)

RETRACTED ARTICLE: Cadherin 6 is activated by Epstein–Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma
por: Zuo, L-L, et al.
Publicado: (2017)

Retraction Note: Cadherin 6 is activated by Epstein–Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma
por: Zuo, L-L, et al.
Publicado: (2022)

Changes in Expression Induced by Epstein-Barr Virus LMP1-CTAR1: Potential Role of bcl3
por: Edwards, Rachel Hood, et al.
Publicado: (2015)

Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia
por: See, Hui Shien, et al.
Publicado: (2008)

Epstein-Barr virus Latent Membrane Protein LMP1 reduces p53 protein levels independent of the PI3K-Akt pathway
por: Husaini, Roslina, et al.
Publicado: (2011)

Epstein–Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis
por: El-Sharkawy, Ahmed, et al.
Publicado: (2018)

Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling
por: Burton, Eric M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gtccmlc6rl89gb0nrrl9lrjrpm